A detailed history of Sectoral Asset Management Inc transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Sectoral Asset Management Inc holds 1,045 shares of MDGL stock, worth $360,713. This represents 0.18% of its overall portfolio holdings.

Number of Shares
1,045
Previous 1,065 1.88%
Holding current value
$360,713
Previous $298,000 25.84%
% of portfolio
0.18%
Previous 0.15%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$212.22 - $292.96 $4,244 - $5,859
-20 Reduced 1.88%
1,045 $221,000
Q2 2024

Aug 13, 2024

SELL
$193.33 - $291.99 $12,759 - $19,271
-66 Reduced 5.84%
1,065 $298,000
Q1 2024

May 14, 2024

SELL
$171.37 - $283.23 $11,995 - $19,826
-70 Reduced 5.83%
1,131 $302,000
Q4 2023

Feb 14, 2024

SELL
$120.4 - $237.13 $2.37 Million - $4.67 Million
-19,700 Reduced 94.25%
1,201 $277,000
Q3 2023

Nov 14, 2023

BUY
$146.04 - $225.78 $279,812 - $432,594
1,916 Added 10.09%
20,901 $3.05 Million
Q2 2023

Aug 11, 2023

BUY
$203.88 - $312.0 $3.77 Million - $5.77 Million
18,485 Added 3697.0%
18,985 $4.39 Million
Q1 2023

May 12, 2023

BUY
$231.06 - $307.08 $115,530 - $153,540
500 New
500 $121,000
Q2 2019

Aug 14, 2019

SELL
$91.13 - $142.5 $3.87 Million - $6.05 Million
-42,487 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$103.48 - $143.84 $1.45 Million - $2.01 Million
14,000 Added 49.15%
42,487 $5.32 Million
Q4 2018

Feb 12, 2019

BUY
$94.77 - $215.54 $246,402 - $560,404
2,600 Added 10.04%
28,487 $3.21 Million
Q3 2018

Nov 14, 2018

SELL
$207.3 - $300.31 $2.54 Million - $3.68 Million
-12,262 Reduced 32.14%
25,887 $5.54 Million
Q2 2018

Aug 13, 2018

SELL
$101.55 - $313.9 $1.27 Million - $3.92 Million
-12,500 Reduced 24.68%
38,149 $10.7 Million
Q1 2018

May 15, 2018

BUY
$93.35 - $149.04 $1.29 Million - $2.06 Million
13,799 Added 37.45%
50,649 $5.92 Million
Q4 2017

Feb 13, 2018

BUY
$39.35 - $97.37 $1.45 Million - $3.59 Million
36,850
36,850 $3.38 Million

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.9B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Sectoral Asset Management Inc Portfolio

Follow Sectoral Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.